Vaccine supply is the real issue weighing on markets: Standard Chartered
Clive McDonnell of Standard Chartered says if vaccine makers are able to overcome production issues, the uptick in supply will help boost growth sentiment.
UP NEXT
UP NEXT
-
Covid-19 relief bill will strengthen pension plans, expand health insurance subsidies
CNBC
-
People are paying millions for digital collectibles known as "NFTs" — What you need to know about this new digital asset
CNBC
-
Cramer: On the cusp of a post-Covid boom, money managers want reopening plays
CNBC
-
Closing the vaccine racial gap
CNBC
-
First female Marine recruits enter bootcamp alongside men
CNBC
-
Mississippi's largest city doesn't have running water, or a timeline for when it will be fixed
CNBC
-
American Electric Power CEO address power outages in Texas snow storm
CNBC
-
Google will stop selling ads based on web browsing history
CNBC
-
Cramer's lightning round: Groupon is a reopening stock
CNBC
-
Rocket attack hits Iraqi airbase hosting U.S. troops
CNBC
-
Wendy's CEO: Breakfast business is doing 'quite well' in face of pandemic
CNBC
-
New York Gov. Cuomo apologizes, but says he won't resign
CNBC
-
Renaissance Macro Research Degraaf: I believe energy has more to run
CNBC
-
President Biden criticizes Texas' decision to ease Covid restrictions
CNBC
-
Why was the National Guard deployment delayed 3 hours on Jan. 6?
CNBC
-
House cancels session tomorrow due to threats of violence by extremists
CNBC
-
Emergent Biosolutions CEO talks production of Johnson & Johnson vaccine
CNBC
-
Jim Cramer: This rotation ends when the economy hits a wall
CNBC
-
CNBC Tech Check Evening Edition: March 03, 2021
CNBC
-
Why Karen's buying Walmart
CNBC
-
Wall Street drops as tech stocks tumble
Reuters
-
The Rocket reversal — What could be the next big Reddit target?
CNBC